Eosinophilic pneumonia epidemiology and demographics
|
Eosinophilic pneumonia Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Eosinophilic pneumonia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Eosinophilic pneumonia epidemiology and demographics |
|
Eosinophilic pneumonia epidemiology and demographics in the news |
|
Blogs on Eosinophilic pneumonia epidemiology and demographics |
|
Risk calculators and risk factors for Eosinophilic pneumonia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
- The incidence of CEP in an Icelandic registry was 0.23 cases/100,000 population per year between 1990 and 2004 [3].
- In registries of interstitial lung disease (ILD) in Europe, CEP accounted for 0 to 2.5 percent of cases of ILD [4].
- A majority of patients are nonsmokers.
- ICEP is a rare disorder. Its exact prevalence remains unknown.
- ICEP has been reported to contribute to 0– 2.5% of cases included in different registries of interstitial lung diseases [1].
- ICEP may affect every age group but is extremely rare in childhood [2-5].
- It is twice as frequent in women as in men [2,3,6,7].
- One third to one half of the ICEP patients have a history of asthma [7-12];
- less than 10% are active smokers [2,3,7].
- It has recently been reported that ICEP may be primed by radiation therapy for breast cancer [13].